Pharmaceutical residues in treated waste water samples according to Directive (EU) 2024/3019

Analysis to determine the concentrations of organic substances (pharmaceuticals and drug precursors) listed in the revised Urban Wastewater Treatment Directive (EU) 2024/3019.

The analysis includes eight substances that can be very easily treated:

  • Amisulprid (CAS: 71675-85-9)

  • Carbamazepine (CAS: 298-46-4)

  • Citalopram (CAS: 59729-33-8)

  • Clarithromycin (CAS: 81103-11-9)

  • Diclofenac (CAS: 15307-86-5)

  • Hydrochlorothiazide (CAS: 58-93-5)

  • Metoprolol (CAS: 37350-58-6)

  • Venlafaxine (CAS: 93413-69-5)

And four substances that can be easily disposed of:

  • Benzotriazole (CAS: 95-14-7)

  • Candesartan (CAS: 139481-59-7)

  • Irbesartan (CAS: 138402-11-6)

  • Mixture of 4-Methylbenzotriazole (CAS No 29878-31-7) and 6-methyl-benzotriazole (CAS No 136-85-6)

This method is suitable for wastewater samples with low total solids and dissolved solids content. Please check the suitability of the sample matrix with the testing expert when requesting an offer.

Suitable sample matrices
Treated waste water
Required sample quantity
50 mL in a dark glass bottle
Typical turnaround time
3 weeks after receiving the samples
Detection limit
Estimated 0.005-0.05 μg/L
Available quality systems
Accredited testing laboratory

Questions? We're happy to help.

Questions? We're happy to help.

Ringing phone
...and more than 700 other happy clients

Ask for an offer

Fill in the form, and we'll reply in one business day.

Answering the following questions helps us prepare an offer for you faster:

  • How many samples do you have and what is the sample material?
  • Do you have a recurring need for these tests? If yes, how often and for how many samples at a time?

Have questions or need help? Email us at or call our sales team.